Prevalence of Sarcopenia Obesity in Patients Treated at a Rural, Multidisciplinary Weight and Wellness Center

• Main Authors: John A Batsis, Diane Gilbert-Diamond, Auden C McClure, Aaron Weintraub, Diane Sette, John N Mecchella, Sivan Rotenberg, Summer B Cook, Richard I Rothstein
• Format: Article
• Language: English
• Published: SAGE Publishing 2019-07-01
• Series: Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders
• Online Access: https://doi.org/10.1177/1179544119862288

Sarcopenic obesity portends poor outcomes, yet it is under-recognized in practice. We collected baseline clinical data including data on body composition (total and segmental muscle mass and total body fat), grip strength, and 5-times sit-to-stand. We defined sarcopenia using cut-points for appendicular lean mass (ALM) and obesity using body-fat cut-points. A total of 599 clinic patients (78.5% female; mean age was 51.3 ± 14.2 years) had bioelectrical impedance analysis (BIA) data (83.8%). Mean body mass index (BMI) and waist circumference were 43.1 ± 8.9 kg/m 2 and 132.3 ± 70.7 cm, respectively. All patients had elevated body fat. There were 284 (47.4%) individuals fulfilling criteria for ALM-defined sarcopenia. Sarcopenic obese persons had a lower BMI (38.2 ± 6.4 vs 47.6 ± 8.6; P  < 0.001), fat-free mass (113.0 kg ± 16.1 vs 152.1 kg ± 29.4; P  < 0.001), fat mass (48.4% ± 5.9 vs 49.5% ± 6.2; P  = 0.03), and visceral adipose tissue (216.8 ± 106.3 vs 242.7 ± 133.6 cm 3 ; P  = 0.009) than those without sarcopenic obesity. Grip strength was lower in those with sarcopenic obesity (25.1 ± 8.0 vs 30.5 ± 11.3 kg; P  < 0.001) and sit-to-stand times were longer (12.4 ± 4.4 vs 10.8 second ± 4.6; P  = 0.03). Sarcopenic obesity was highly prevalent in a rural, tertiary care weight and wellness center.